DROSPIRENONE/ ETHINYLOESTRADIOL-GH TABLETS 3 mg/30 micrograms drospirenone/ethinylestradiol 3 mg/30 micrograms tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

drospirenone/ ethinyloestradiol-gh tablets 3 mg/30 micrograms drospirenone/ethinylestradiol 3 mg/30 micrograms tablet blister pack

lupin australia pty limited - drospirenone, quantity: 3 mg; ethinylestradiol, quantity: 30 microgram - tablet - excipient ingredients: lactose monohydrate; maize starch; pregelatinised maize starch; magnesium stearate; titanium dioxide; hypromellose; macrogol 400 - for use as an oral contraceptive

DROSPIRENONE/ ETHINYLOESTRADIOL-LUPIN TABLETS 3 mg/30 micrograms drospirenone/ethinylestradiol 3 mg/30 micrograms tablet blister Australia - English - Department of Health (Therapeutic Goods Administration)

drospirenone/ ethinyloestradiol-lupin tablets 3 mg/30 micrograms drospirenone/ethinylestradiol 3 mg/30 micrograms tablet blister

lupin australia pty limited - drospirenone, quantity: 3 mg; ethinylestradiol, quantity: 30 microgram - tablet - excipient ingredients: lactose monohydrate; maize starch; pregelatinised maize starch; magnesium stearate; titanium dioxide; hypromellose; macrogol 400 - for use as an oral contraceptive

Elvinette 0.02mg/3mg film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

elvinette 0.02mg/3mg film-coated tablets

gedeon richter plc - drospirenone; ethinylestradiol - film-coated tablet - 0.02 mg/3 milligram(s) - progestogens and estrogens, fixed combinations; drospirenone and ethinylestradiol

Roxina 0.02 mg/3 mg film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

roxina 0.02 mg/3 mg film-coated tablets

gedeon richter plc - ethinylestradiol; drospirenone - film-coated tablet - 0.02 mg/3 milligram(s) - progestogens and estrogens, fixed combinations; drospirenone and ethinylestradiol

Yasminelle 0,02 mg - 3 mg Film-coated tablet Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

yasminelle 0,02 mg - 3 mg film-coated tablet

impexeco - drospirenone; ethinylestradiol betadex clathrate - film-coated tablet - 0,02 mg - 3 mg - drospirenone 3 mg; ethinylestradiol betadex clathrate - drospirenone and ethinylestradiol

ETHINYLESTRADIOL / DROSPIRENONE LEON FARMA 0.02 / 3 Milligram Film Coated Tablet Ireland - English - HPRA (Health Products Regulatory Authority)

ethinylestradiol / drospirenone leon farma 0.02 / 3 milligram film coated tablet

laboratorios leon farma, s.a. - drospirenone ethinylestradiol - film coated tablet - 0.02 / 3 milligram

Yasminelle 0.02 mg/3 mg film-coated tablets Malta - English - Medicines Authority

yasminelle 0.02 mg/3 mg film-coated tablets

neofarma pharmaceuticals limited 42-46, mill street, qormi, qrm 3105, malta - ethinylestradiol, drospirenone - film-coated tablet - ethinylestradiol 0.02 mg drospirenone 3 mg - sex hormones and modulators of the genital system

Freedonel 0.02 mg/3 mg film-coated tablets Malta - English - Medicines Authority

freedonel 0.02 mg/3 mg film-coated tablets

rowex ltd newtown bantry, co. cork, , ireland - ethinylestradiol, drospirenone - film-coated tablet - ethinylestradiol 0.02 mg drospirenone 3 mg - sex hormones and modulators of the genital system

Yasminelle 0.02 mg/3 mg film-coated tablets Malta - English - Medicines Authority

yasminelle 0.02 mg/3 mg film-coated tablets

nm pharma limited 3/4, cantrija complex triq it-targa, il-maghtab naxxar nxr 6613 , malta - ethinylestradiol, drospirenone - film-coated tablet - ethinylestradiol 0.02 mg drospirenone 3 mg - agents acting on the renin-angiotensin system

Yaz New Zealand - English - Medsafe (Medicines Safety Authority)

yaz

bayer new zealand limited - drospirenone 3mg (micro 15); ethinylestradiol betadex clathrate 0.02mg (ethinylestradiol betadex clathrade amount equivalent ethinylestradiol 0.02mg) - tablet - 3mg/0.02mg - active: drospirenone 3mg (micro 15) ethinylestradiol betadex clathrate 0.02mg (ethinylestradiol betadex clathrade amount equivalent ethinylestradiol 0.02mg) excipient: lactose monohydrate magnesium stearate maize starch opadry pink 02a34744 hypromellose lactose monohydrate magnesium stearate microcrystalline cellulose purified talc titanium dioxide hypromellose lactose monohydrate magnesium stearate maize starch povidone purified talc titanium dioxide - yaz is indicated for use as: - an oral contraceptive. - treatment of moderate acne vulgaris in women who seek oral contraception. - treatment of symptoms of premenstrual dysphoric disorder (pmdd) in women who have chosen oral contraceptives as their method of birth control. the efficacy of yaz for pmdd was not assessed beyond 3 cycles. yaz has not been evaluated for treatment of pms (premenstrual syndrome).